RNA Therapeutics pp 85-89 | Cite as
Systemic Delivery of Synthetic siRNAs
Protocol
First Online:
- 1 Citations
- 3 Mentions
- 3.8k Downloads
Abstract
RNA interference is a biological process for gene silencing that can be harnessed for the development of new drugs. However, a major obstacle to the use of small interfering RNAs (siRNAs) as therapeutics is their delivery across the plasma membrane of cells in vivo. A range of solutions for this challenge have been described, including cationic lipids, high-pressure injection, viral vectors, and chemical modifications of the siRNAs. This chapter describes cationic lipid delivery of siRNAs to adult mice.
Key words
RNA interference siRNA cationic lipidsReferences
- 1.Sioud, M. (2001) Nucleic acid enzymes as a novel generation of anti-gene agents. Curr Mol Med, 1, 575–588.PubMedCrossRefGoogle Scholar
- 2.Behlke, M.A. (2006) Progress towards in vivo use of siRNAs. Mol Ther, 13, 644–666.PubMedCrossRefGoogle Scholar
- 3.Fire, A., Xu, S., Montgomery, M.K., Kostas, S.A., Driver, S.E., and Mello, C.C. (1998) Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature, 391, 806–811.PubMedCrossRefGoogle Scholar
- 4.Elbashir, S.M., Harborth, J., Lendeckel, W., Yalcin, A., Weber, K., and Tuschl, T. (2001) Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature, 411, 494–498.PubMedCrossRefGoogle Scholar
- 5.Sioud, M. (2004) Therapeutic siRNAs. Trends Pharmacol Sci, 25, 22–28.PubMedCrossRefGoogle Scholar
- 6.Templeton, S.N. (2002) Liposomal delivery of nucleic acids in vivo. DNA Cell Biol, 21, 859–867.Google Scholar
- 7.Sørensen, D.R., Leirdal, M., and Sioud, M. (2003) Gene silencing by systemic delivery of synthetic siRNAs in adult mice. J Mol Biol, 327, 761–766.PubMedCrossRefGoogle Scholar
- 8.Morrissey, D.V., Lockridge, J.A., Shaw, L., Blanchard, K., Jensen, K., Breen, W., Hartsough, K., Machemer, L., Radka, S., Jadhav, V., Vaish, N., Zinnen, S., Vargeese, C., Bowman, K., Shaffer, C.S., Jeffs, L.B., Judge, A., MacLachlan, I., and Polisky, B. (2005) Potent and persistent in vivo anti-HBV activity of chemically modified siRNAs. Nat Biotechnol, 23, 1002–1100.PubMedCrossRefGoogle Scholar
- 9.Sioud, M. (2005) On the delivery of small interfering RNAs into mammalian cells. Expert Opin Drug Deliv, 2, 639–651.PubMedCrossRefGoogle Scholar
Copyright information
© Springer Science+Business Media, LLC 2010